HIVManagement.org

 

Quick Menu / Table of Contents
Introduction Principles Management NRTI Key NRTI Info
NNRTI Key NNRTI Info PI Key PI Info Fusion Inhibitors
Drug Summary Investigational Adherence Lab Evaluation Resistance Tests
PEP Antiretroviral Tables OI Prevention Vaccinations TB Therapy
Hepatitis Therapy OI Diagnosis OI Therapy Bibliography Links
| Palliative Care | Presentations |

 

zidovudine - lamivudine - abacavir [Trizivir]

Detailed Prescribing Information

October 2005

 

Trizivir
A combination of zidovudine + lamivudine + abacavir
Forms Available 300 mg zidovudine / 150 mg lamivudine in tablets / 300 mg abacavir in tablets
Dosing 1 tablet twice a day
Renal dosing: not recommended
Hepatic dosing: not recommended
Food dependence This medication is best taken on an empty stomach.
Adverse Effects Same as zidovudine plus lamivudine plus abacavir
Interactions Same as zidovudine plus lamivudine plus abacavir
Suggested lab follow-up Monthly CBC x 3 months, then q3months if stable
Warning 5% incidence of abacavir hypersensitivity (see abacavir above)

Rare lactic acidosis and hepatic steatosis.
Possible flare of hepatitis B if Trizivir is discontinued suddenly.

Contraindication Previous abacavir hypersensitivity

Suggested administration protocol

Click HERE to review abacavir administration protocol

Suggested Usage

Do not use in combination with lamivudine, emtricitabine, Truvada, Epzicom, or Combivir due to identical mechanism of action or duplication of lamivudine dosing.
Do not use Trizivir with stavudine due to antagonism with the zidovudine component.

Complete prescribing information

Trizivir Prescribing Info

 

 

Links to Antiretroviral Sections (click on anything)
Nucleoside & Nucleotide Reverse Transcriptase Inhibitors (NRTI)
AZT  |  ddC  |  ddI  |  d4T  |  3TC  |  ABC  |  FTC  |  TDF  |  Combivir  |  Trizivir  |  Epzicom  |  Truvada
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTI)
efavirenz  |  nevirapine  |  delavirdine
Protease Inhibitors (PI)  |  Boosted Protease Inhibitors
saquinavir  indinavir  |  ritonavir  |  nelfinavir  |  amprenavir  |  lopinavir + ritonavir  |  atazanavir  |  fosamprenavir  | tipranavir
Fusion Inhibitors
enfuvirtide

 

 

Quick Menu / Table of Contents
Introduction Principles Management NRTI Key NRTI Info
NNRTI Key NNRTI Info PI Key PI Info Fusion Inhibitors
Drug Summary Investigational Adherence Lab Evaluation Resistance Tests
PEP Antiretroviral Tables OI Prevention Vaccinations TB Therapy
Hepatitis Therapy OI Diagnosis OI Therapy Bibliography Links

 

Updated 10.25.2005

 


 

1. Renal dosing information from: Ian R. McNicholl & Rudolph A. Rodriguez, MD, Dosing of Antiretroviral Drugs in Renal Insufficiency and Hemodialysis, May 2004
http://hivinsite.ucsf.edu/InSite?page=md-rr-18